论文部分内容阅读
目的观察匹多莫德治疗小儿反复下呼吸道感染的临床疗效。方法选取随州市中心医院2014年8月—2015年8月收治的反复下呼吸道感染患儿120例,按照入院顺序分为对照组和观察组,每组60例。对照组患儿采用常规治疗,观察组患儿常规治疗基础上加用匹多莫德口服液;两组患儿均连续治疗60 d。比较两组患儿临床疗效、治疗前后两组免疫球蛋白水平、临床症状及体征消失时间。结果观察组患儿临床疗效优于对照组(P<0.05)。治疗前两组患儿免疫球蛋白A(IgA)、免疫球蛋白G(IgG)、免疫球蛋白M(Ig M)水平比较,差异无统计学意义(P>0.05);治疗后观察组患儿IgA、IgG、IgM高于对照组(P<0.05)。观察组患儿肺部啰音消失时间、退热时间、咳嗽缓解时间短于对照组(P<0.05)。结论匹多莫德治疗小儿反复下呼吸道感染的临床疗效确切,可有效改善患儿免疫功能,缩短临床症状及体征消失时间。
Objective To observe the clinical efficacy of pidotimod in children with recurrent lower respiratory tract infection. Methods 120 cases of recurrent lower respiratory tract infection in Suizhou Central Hospital from August 2014 to August 2015 were selected and divided into control group and observation group according to admission sequence, with 60 cases in each group. The control group of children with conventional treatment, the treatment group on the basis of conventional treatment with Pidotimod oral solution; two groups of children were treated for 60 days. The clinical efficacy of the two groups were compared. The levels of immunoglobulin, clinical symptoms and signs disappeared before and after treatment in both groups. Results The clinical efficacy of observation group was better than that of control group (P <0.05). Before treatment, the levels of immunoglobulin A (IgA), immunoglobulin G (IgG) and immunoglobulin M (IgM) in the two groups had no significant difference (P> 0.05). After treatment, the children in observation group IgA, IgG, IgM higher than the control group (P <0.05). The observation group patients with pulmonary rales disappear time, antipyretic time, cough relief time shorter than the control group (P <0.05). Conclusion Pidotimod treatment of children with repeated lower respiratory tract infection in the clinical curative effect is exact, can effectively improve children’s immune function, shorten the clinical symptoms and signs of disappearance time.